INTERNATIONAL PATENT: GNUBIOTICS SCIENCES SA FILES APPLICATION FOR "GLYCAN PROGRAMMED CELL THERAPY"

GENEVA, Sept. 21 -- GNUBIOTICS SCIENCES SA (StartLab, Biopole, Bat SE-BRoute de la Corniche 51066 Epalinges, Lausanne) filed a patent application (PCT/IB2025/052698) for "GLYCAN PROGRAMMED CELL THERAPY" on Mar 14, 2025. With publication no. WO/2025/191521, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ADESOKAN, Adeyemi (c/o Gnubiotics SA, StartLab, Biopole, Bat SE-BRoute de la Corniche 51066 Epalinges, Lausanne)

Abstract: Provided herein are methods treating cancer by administering to a recipient mammal reprogrammed ...